Methyl 5-((3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)methyl)furan-2-carboxylate

Catalog No. :
ACVEDB912
CAS No. :
402617-00-9
Molecular Formula :
C12H13N3O5
Molecular Weight :
279.25

IUPAC Name:methyl 5-((3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)methyl)furan-2-carboxylate

Methyl 5-((3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)methyl)furan-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$552.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-((3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)methyl)furan-2-carboxylate
IUPAC Namemethyl 5-((3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)methyl)furan-2-carboxylate
Molecular FormulaC12H13N3O5
Molecular Weight279.25
SMILESO=C(C1=CC=C(CN2N=C(C)C([N+]([O-])=O)=C2C)O1)OC
InChI KeyNKMLPDFXBCJEHK-UHFFFAOYSA-N
SynonymTIMTEC-BB SBB009197;ART-CHEM-BB B001103;METHYL 5-[(3,5-DIMETHYL-4-NITRO-1H-PYRAZOL-1-YL)METHYL]-2-FUROATE;AKOS B001103;5-(3,5-DIMETHYL-4-NITRO-PYRAZOL-1-YLMETHYL)-FURAN-2-CARBOXYLIC ACID METHYL ESTER;5-(3,5-DIMETHYL-4-NITRO-PYRAZOL-1-YLMETHYL)-FURAN-2-CARBOXYLIC ACID METHY+;2-Furancarboxylic acid, 5-[(3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)methyl]-, methyl ester
CAS No.402617-00-9

Synthetic Route by SureRoute

1. ACVEDB912 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPACR581 route compound structure diagram
    ACPACR58114531-55-6 In Stock
  4. Then
  5. ACVEDB912 route product structure diagram
    ACVEDB912402617-00-9
Inquiry

2. ACVEDB912 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOOGR776 route compound structure diagram
    ACOOGR77670117-25-8 In Stock
  2. Plus
  3. ACPACR581 route compound structure diagram
    ACPACR58114531-55-6 In Stock
  4. Then
  5. ACVEDB912 route product structure diagram
    ACVEDB912402617-00-9
Inquiry

Comments (0)